Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.

@article{Jordan2007GuidelinesFA,
  title={Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.},
  author={K. Jordan and C. Sippel and H. Schmoll},
  journal={The oncologist},
  year={2007},
  volume={12 9},
  pages={
          1143-50
        }
}
Clinicians should be aware that chemotherapy-induced nausea and vomiting (CINV) is still one of the most feared side effects of chemotherapy. With the correct use of antiemetics, CINV can be prevented in almost 70% to up to 80% of patients. Treatment guidelines are useful tools that enable physicians to integrate the latest clinical research into their practices. The large volume of rapidly evolving clinical data has been summarized and incorporated into treatment recommendations by well-known… Expand
178 Citations

Tables and Topics from this paper

Paper Mentions

Interventional Clinical Trial
This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy… Expand
ConditionsPostoperative Nausea and Vomiting, Postoperative Pain
InterventionDrug
Antiemetics: an update and the MASCC guidelines applied in clinical practice
  • 109
  • PDF
Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.
  • 23
  • PDF
Management of chemotherapy-induced nausea and vomiting
  • 32
  • PDF
Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital
  • 20
Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
  • 23
Evaluation of anti-emetic use in chemotherapy-induced nausea and vomiting in a third-world country (Lebanon).
  • 4
Evaluation of Adherence to Antiemetic Treatment Guidelines in Patients With Chemotherapy-Induced Nausea and Vomiting in Teaching Hospitals in Tehran
  • 1
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
  • R. Gralla, D. Osoba, +12 authors D. Pfister
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1999
  • 642
  • PDF
Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis.
  • S. Grunberg
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2007
  • 124
Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.
  • 290
Comparative activity of antiemetic drugs.
  • 84
Nausea and emesis: still an unsolved problem in cancer patients?
  • 25
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
  • M. Kris, P. Hesketh, +8 authors S. Grunberg
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
  • 700
  • PDF
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
  • 420
  • PDF
...
1
2
3
4
...